KEGG   DRUG: クレネズマブ
エントリ  
D10101                      Drug                                   
一般名   
クレネズマブ (遺伝子組換え) (JAN);
Crenezumab (USAN);
Crenezumab (genetical recombination) (JAN)
組成式   
C6348H9796N1688O2010S44
質量    
143242.3925
分子量   
143330.75
配列    
(Heavy chain)
EVQLVESGGG LVQPGGSLRL SCAASGFTFS SYGMSWVRQA PGKGLELVAS INSNGGSTYY
PDSVKGRFTI SRDNAKNSLY LQMNSLRAED TAVYYCASGD YWGQGTTVTV SSASTKGPSV
FPLAPCSRST SESTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV
VTVPSSSLGT KTYTCNVDHK PSNTKVDKRV ESKYGPPCPP CPAPEFLGGP SVFLFPPKPK
DTLMISRTPE VTCVVVDVSQ EDPEVQFNWY VDGVEVHNAK TKPREEQFNS TYRVVSVLTV
LHQDWLNGKE YKCKVSNKGL PSSIEKTISK AKGQPREPQV YTLPPSQEEM TKNQVSLTCL
VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS RLTVDKSRWQ EGNVFSCSVM
HEALHNHYTQ KSLSLSLG
(Light chain)
DIVMTQSPLS LPVTPGEPAS ISCRSSQSLV YSNGDTYLHW YLQKPGQSPQ LLIYKVSNRF
SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YYCSQSTHVP WTFGQGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H126-L219, H139-H195, H218-H'218, H221-H'221, H253-H313, H359-H417, H'22-H'96, H'126-L'219, H'139-H'195, H'253-H'313, H'359-H'417, L23-L93, L139-L199, L'23-L'199)
  タイプ
Peptide
効能    
認知症治療薬
  タイプ
モノクローナル抗体
ターゲット 
Amyloid beta [CPD:C16514 C16515]
リンク   
CAS: 1095207-05-8
PubChem: 135626819
LinkDB    

» English version   » Back

DBGET integrated database retrieval system